FI891710A0 - Menetelmä kedarsidiini-antibiootin valmistamiseksi - Google Patents

Menetelmä kedarsidiini-antibiootin valmistamiseksi

Info

Publication number
FI891710A0
FI891710A0 FI891710A FI891710A FI891710A0 FI 891710 A0 FI891710 A0 FI 891710A0 FI 891710 A FI891710 A FI 891710A FI 891710 A FI891710 A FI 891710A FI 891710 A0 FI891710 A0 FI 891710A0
Authority
FI
Finland
Prior art keywords
antibiotic
kedaridine
preparing
kedarcidin
protein
Prior art date
Application number
FI891710A
Other languages
English (en)
Swedish (sv)
Other versions
FI93969B (fi
FI93969C (fi
FI891710A (fi
Inventor
Sandra J Hofstead
James Andrew Matson
Kin Sing Lam
Salvatore Forenza
James A Bush
Koji Tomita
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI891710A0 publication Critical patent/FI891710A0/fi
Publication of FI891710A publication Critical patent/FI891710A/fi
Publication of FI93969B publication Critical patent/FI93969B/fi
Application granted granted Critical
Publication of FI93969C publication Critical patent/FI93969C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI891710A 1988-04-12 1989-04-11 Menetelmä kedarsidiini-antibiootin valmistamiseksi FI93969C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18051988A 1988-04-12 1988-04-12
US18051988 1988-04-12
US32300189 1989-03-17
US07/323,001 US5001112A (en) 1988-04-12 1989-03-17 Antitumor antibiotic kedarcidin

Publications (4)

Publication Number Publication Date
FI891710A0 true FI891710A0 (fi) 1989-04-11
FI891710A FI891710A (fi) 1989-10-13
FI93969B FI93969B (fi) 1995-03-15
FI93969C FI93969C (fi) 1995-06-26

Family

ID=26876396

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891710A FI93969C (fi) 1988-04-12 1989-04-11 Menetelmä kedarsidiini-antibiootin valmistamiseksi

Country Status (24)

Country Link
US (1) US5001112A (fi)
EP (1) EP0337430B1 (fi)
JP (1) JP2850132B2 (fi)
KR (1) KR970010137B1 (fi)
CN (1) CN1034589C (fi)
AT (1) ATE101653T1 (fi)
AU (1) AU623641B2 (fi)
CA (1) CA1338262C (fi)
CY (1) CY1849A (fi)
DE (1) DE68913063T2 (fi)
DK (1) DK174751B1 (fi)
ES (1) ES2061760T3 (fi)
FI (1) FI93969C (fi)
HK (1) HK83195A (fi)
HU (1) HU201119B (fi)
IE (1) IE62912B1 (fi)
IL (1) IL89896A0 (fi)
MY (1) MY105842A (fi)
NO (1) NO174474C (fi)
NZ (1) NZ228672A (fi)
PL (1) PL161004B1 (fi)
PT (1) PT90252B (fi)
SG (1) SG30654G (fi)
YU (1) YU73989A (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143906A (en) * 1991-09-26 1992-09-01 Bristol-Myers Squibb Company Kedarcidin antitumor chromophore and pharmaceutical composition containing same
WO2003062458A2 (en) * 2002-01-24 2003-07-31 Ecopia Biosciences Inc. Method, system and knowledge repository for identifying a secondary metabolite from a microorganism
HUE029265T2 (en) * 2008-10-27 2017-02-28 Glaxosmithkline Biologicals Sa Method of purifying carbohydrates from the group streptococci

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS519837B2 (fi) * 1974-03-29 1976-03-30
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS6017206B2 (ja) * 1977-03-24 1985-05-01 浩 前田 ネオカルチノスタチン誘導体の製造法
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation
JPS57206693A (en) * 1981-06-10 1982-12-18 Ajinomoto Co Inc Protein an-7d
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物

Also Published As

Publication number Publication date
DE68913063D1 (de) 1994-03-24
JP2850132B2 (ja) 1999-01-27
JPH01317396A (ja) 1989-12-22
DK174751B1 (da) 2003-10-20
FI93969B (fi) 1995-03-15
HK83195A (en) 1995-06-01
ES2061760T3 (es) 1994-12-16
PT90252B (pt) 1994-07-29
IE62912B1 (en) 1995-03-08
PL161004B1 (pl) 1993-05-31
HUT50880A (en) 1990-03-28
PL278782A1 (en) 1989-12-27
CY1849A (en) 1996-03-08
EP0337430A3 (en) 1991-07-24
NO174474B (no) 1994-01-31
AU3272889A (en) 1989-10-19
EP0337430A2 (en) 1989-10-18
IE891157L (en) 1989-10-12
CA1338262C (en) 1996-04-23
US5001112A (en) 1991-03-19
FI93969C (fi) 1995-06-26
DK173589A (da) 1989-10-13
SG30654G (en) 1995-09-01
NO174474C (no) 1998-06-09
FI891710A (fi) 1989-10-13
MY105842A (en) 1995-01-30
CN1034589C (zh) 1997-04-16
CN1037735A (zh) 1989-12-06
DE68913063T2 (de) 1994-06-09
NO891462L (no) 1989-10-13
AU623641B2 (en) 1992-05-21
DK173589D0 (da) 1989-04-11
KR900016469A (ko) 1990-11-13
KR970010137B1 (ko) 1997-06-21
NO891462D0 (no) 1989-04-10
ATE101653T1 (de) 1994-03-15
EP0337430B1 (en) 1994-02-16
NZ228672A (en) 1990-07-26
YU73989A (en) 1991-04-30
IL89896A0 (en) 1989-12-15
PT90252A (pt) 1989-11-10
HU201119B (en) 1990-09-28

Similar Documents

Publication Publication Date Title
EP0723013A3 (en) Biosynthetic osteogenic proteins and osteogenic devices containing them
AU5245186A (en) Oxidation resistant mutant proteins
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
EP0489711A3 (en) Method for producing human growth hormone
ATE107362T1 (de) Polypeptid-mutanten des menschlichen tnf und für diese mutanten codierende dns.
DE3569112D1 (en) 4,5-dihydro-4-oxo-2- û(2-trans-phenylcyclopropyl)amino¨-3-furancarboxylic acids and derivatives thereof
FI891710A0 (fi) Menetelmä kedarsidiini-antibiootin valmistamiseksi
PH31198A (en) Protein recognized by antibodies raised against native P28 of schitosoma mansoni.
DE58908428D1 (de) Sekretormutante von Escherichia coli.
AU2569588A (en) A method for the selective cleavage of fusion proteins
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
AU3810389A (en) Process for extracting and purifying epidermin

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: BRISTOL-MYERS SQUIBB COMPANY

MA Patent expired